Prices delayed by at least 15 minutes | Print
Ishares Iv PLC ISH NASDAQ US BTEC UCITS ETF USD DIST
Open
$10.396
Previous close
$10.385
Trade high
$10.482
Income frequency
Semi-annually
Year low
$7.932
Year high
$10.878
Replication method
Physical Full
Volume
181,729
Type
ETF
UCITS
Yes
Dividend yield
0.21%
Ongoing charge
0.35
ISIN
IE00BDZVHG35
Share price
Asset allocation
Top 10 holdings
| Holdings 13/11/2026 | % of assets |
|---|---|
| Gilead Sciences Inc | 9.07 |
| Amgen Inc | 8.53 |
| Vertex Pharmaceuticals Inc | 7.80 |
| Regeneron Pharmaceuticals Inc | 6.24 |
| Moderna Inc | 5.76 |
| Biogen Inc | 2.42 |
| Revolution Medicines Inc Ordinary Shares | 2.38 |
| Illumina Inc | 2.02 |
| Royalty Pharma PLC Class A | 1.99 |
| Roivant Sciences Ltd Ordinary Shares | 1.84 |
Investment objective
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.